Steeg P S, Theodorescu D. Metastasis: a therapeutic target for cancer[J]. Nat Clin Pract Oncol, 2008, 5:206.
[3]
Humphries J D, Byron A, Humphries M J. Integrin ligands at a glance[J]. J Cell Sci, 2006, 119: 3901.
[4]
Wang Heyong, Wu Chunlian, Wan Shengbang, et al. Shikonin attenuates lung cancer cell adhesion to extracellular matrix and metastasis by inhibiting integrin β1 expression and the ERK1/2 signaling pathway[J]. Toxicology, 2013, 308: 104.
[5]
Thakur S, Li L, Gupta S. NF-κB-mediated integrin-linked kinase regulation in angiotensin Ⅱ-induced pro-fibrotic process in cardiac fibroblasts[J]. Life Sci, 2014,107(1/2):68.
[6]
Ma W L, Jeng L B, Lai H C, et al. Androgen receptor enhances cell adhesion and decreases cell migration via modulating β1-integrin-AKT signaling in hepatocellular carcinoma cells[J]. Cancer Lett, 2014, 1(351): 64.
[7]
Ke C, Jin H, Cai J. AFM studied the effect of celastrol on β1 integrin-mediated HUVEC adhesion and migration[J]. Scanning, 2013, 35(5): 316.
[8]
Zhu H, Liu X W, Cai T Y, et al. Celastrol acts as a potent antimetastatic agent targeting bata1integrin and inhibiting cell-extracellular matrix adhesion, in part via the p38 mitogen-activated protein kinase pathway[J]. J Pharmacol Exp Ther, 2010, 334(2):489.
[9]
Xie C, Jiang G, Fan C, et al. ARMC8α promotes proliferation and invasion of non-small cell lung cancer cells by activating the canonical Wnt signaling pathway[J]. Tumour Biol, 2014,35(9):8903.
[10]
Liu J, Shen W, Tang Y, et al. Proteasome inhibitor MG132 enhances the antigrowth and antimetastasis effects of radiation in human nonsmallcell lung cancer cells[J]. Tumour Biol, 2014, 35(8):7531.
[11]
Chambers S K, Dunn J, Occhipinti S, et al. A systematic review of the impact of stigma and nihilism on lung cancer outcomes[J]. BMC Cancer, 2012, 12:184.
[12]
Steeg P S, Theodorescu D. Metastasis: a therapeutic target for cancer[J]. Nat Clin Pract Oncol, 2008, 5(4): 206.
[13]
Gupta G P, Massagué J. Cancer metastasis: building a framework[J]. Cell, 2006, 127(4): 679.
[14]
Li F, Liu Y, Kan X, et al. Elevated expression of integrin αv and β5 subunit in laryngeal squamous-cell carcinoma associated with lymphatic metastasis and angiogenesis[J]. Pathol Res Pract, 2013, 209(2):105.
Kannaiyan R, Shanmugam M K, Sethi G. Molecular targets of celastrol derived from Thunder of God Vine: potential role in the treatment of inflammatory disorders and cancer[J]. Cancer Lett, 2011, 303(1):9.
[18]
Boridy S, Le P U, Petrecca K, et al. Celastrol targets proteostasis and acts synergistically with a heat-shock protein 90 inhibitor to kill human glioblastoma cells[J]. Cell Death Dis, 2014, 5: e1216.
[19]
Ma J, Han L Z, Liang H, et al. Celastrol inhibits the HIF-1α pathway by inhibition of mTOR/p70S6K/eIF4E and ERK1/2 phosphorylation in human hepatoma cells[J]. Oncol Rep, 2014, 32(1):235.
[20]
Zhao X, Gao S, Ren H, et al. Inhibition of autophagy strengthens celastrol-induced apoptosis in human pancreatic cancer in vitro and in vivo models[J]. Curr Mol Med, 2014, 14(4):555.
